Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-21 Purchase | 2024-10-23 7:49 pm | Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director | 145,000 | $1.37 | $198,650 | 205,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-21 Option Award | 2024-10-23 7:49 pm | N/A 2034-10-21 | Inhibikase Therapeutics Inc. | IKT | Kush Arvind Director | 60,000 | $0 | 205,000 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:42 pm | N/A 2031-12-14 | RayzeBio Inc. | RYZB | Kush Arvind CHIEF FINANCIAL OFFICER | 615,522 | $0 | 0 (Direct) | View |
| 2024-02-26 Disposition | 2024-02-27 4:42 pm | N/A N/A | RayzeBio Inc. | RYZB | Kush Arvind CHIEF FINANCIAL OFFICER | 78,433 | $62.5 | 0 (Direct) | View |
| 2023-11-17 Option Award | 2023-11-17 6:38 pm | N/A 2033-11-16 | RayzeBio Inc. | RYZB | Kush Arvind Chief Financial Officer | 164,000 | $0 | 164,000 (Direct) | View |
Ownership | 2023-09-14 7:39 pm | N/A N/A | RayzeBio Inc. | RYZB | Kush Arvind Chief Financial Officer | 0 | $0 | 529,079 (Direct) | View |